Large study tests new drug combinations for advanced cervical cancer
Disease control
Not yet recruiting
This study aims to observe the safety and effectiveness of treatments involving the drugs camrelizumab or famitinib for women with recurrent or metastatic cervical cancer. It will follow about 1,300 patients who have already decided to receive one of these treatments as part of t…
Sponsor: Qi Zhou • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC